Efficacy and Safety of Therapies for Systemic Sclerosis-Associated Interstitial Lung Disease: A Bayesian Network Meta-Analysis
{{output}}
Rationale: Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a leading cause of morbidity and mortality in scleroderma. Multiple immunomodulatory and antifibrotic therapies have been evaluated, but their compar... ...
